Atlas Trials

Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

Clinical trial NCT01681576 · COMPLETED

Trial details

NCT number
NCT01681576
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Salt-sensitive Hypertension
Start date
2012-08-01
Primary completion
2013-10-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.